Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.
Keyword(s):
Keyword(s):
2011 ◽
Vol 66
(12)
◽
pp. 2850-2855
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 2
(Supplement_2)
◽
pp. 101-102
◽
Keyword(s):